Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 DiabetesZOUNGAS, S; CHALMERS, J; COOPER, M. E et al.The New England journal of medicine. 2014, Vol 371, Num 15, pp 1392-1406, issn 0028-4793, 15 p.Article

ADVANCE and glycaemia thresholds: a need to clarify the statistical approach. Reply to Currie CJ [letter]ZOUNGAS, S; CHALMERS, J; LI, Q et al.Diabetologia (Berlin). 2012, Vol 55, Num 8, issn 0012-186X, p. 2300Article

Treatment of Dyslipidemia and Cardiovascular Outcomes:The Journey So Far—Is This the End for Statins?ZOUNGAS, S; CURTIS, A. J; MCNEIL, J. J et al.Clinical pharmacology and therapeutics. 2014, Vol 96, Num 2, pp 192-205, issn 0009-9236, 14 p.Article

Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitusHILLIS, G. S; WOODWARD, M; MANCIA, G et al.Diabetologia (Berlin). 2012, Vol 55, Num 5, pp 1283-1290, issn 0012-186X, 8 p.Article

Intensive glucose control and risk of cancer in patients with type 2 diabetesSTEFANSDOTTIR, G; ZOUNGAS, S; CHALMERS, J et al.Diabetologia (Berlin). 2011, Vol 54, Num 7, pp 1608-1614, issn 0012-186X, 7 p.Article

The effects of patient characteristics and geographical region on hospitalization in patients with Type 2 diabetesZAMAN, M. J; PATEL, A; CHALMERS, J et al.Diabetic medicine. 2013, Vol 30, Num 8, pp 918-925, issn 0742-3071, 8 p.Article

Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trialBATTY, G.-D; LI, Q; PATEL, A et al.European psychiatry. 2013, Vol 28, Num 1, pp 49-52, issn 0924-9338, 4 p.Article

Association of HbA_1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholdsZOUNGAS, S; CHALMERS, J; HELLER, S et al.Diabetologia (Berlin). 2012, Vol 55, Num 3, pp 636-643, issn 0012-186X, 8 p.Article

Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trialLI, Q; CHALMERS, J; BATTY, G. D et al.Diabetologia (Berlin). 2010, Vol 53, Num 11, pp 2320-2327, issn 0012-186X, 8 p.Article

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) StudyKENGNE, A. P; PATEL, A; CHALMERS, J et al.Diabetologia (Berlin). 2010, Vol 53, Num 5, pp 821-831, issn 0012-186X, 11 p.Article

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trialDE GALAN, B. E; ZOUNGAS, S; HELLER, S. R et al.Diabetologia (Berlin). 2009, Vol 52, Num 11, pp 2328-2336, issn 0012-186X, 9 p.Article

Randomized, placebo-controlled trial of intramuscular vitamin B₁₂ for the treatment of hyperhomocysteinaemia in dialysis patientsPOLKINGHORNE, K. R; ZOUNGAS, S; BRANLEY, P et al.Internal medicine journal (Print). 2003, Vol 33, Num 11, pp 489-494, issn 1444-0903, 6 p.Article